Roche glucose monitors removed from NY Medicaid program

The state of New York's Medicaid system has booted Roche Diagnostics' glucose strips and monitors from its preferred manufacturer list, Mass Device reports, and this move could cost the company millions of customers. In its latest issue of the New York State Medicaid Update, regulators modified the state's diabetic supply program to include only three manufacturers, Abbott Laboratories, Bayer and LifeScan, a subsidiary of Johnson & Johnson. Glucose strips and monitors made by Roche were taken off the list effective March 1. Story  

Suggested Articles

Medtronic has moved to acquire Avenu Medical, developers of a minimally invasive method of building the blood vessel access ports.

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.